The research analyzed data from over 10,000 individuals taking dihydropyridines and 50,000 control subjects. The findings indicated that individuals taking high doses of nifedipine were significantly more likely to experience an out-of-hospital cardiac arrest compared to those not using dihydropyridines or those taking amlodipine.
Laboratory Insights
To explore the reasons behind the differing effects of nifedipine and amlodipine, scientists conducted laboratory experiments. Both drugs work by blocking L-type calcium channels, which can shorten the action potential of cardiac cells. This shortening, in turn, could potentially trigger arrhythmias leading to cardiac arrest. The in vitro studies revealed that high doses of nifedipine caused a more pronounced shortening of action potentials than high-dose amlodipine, aligning with the population study’s results.
Expert Commentary and Future Directions
Dr. Hanno Tan, the project leader for ESCAPE-NET, emphasized that while the findings are suggestive, they need to be replicated in further studies with larger participant groups and diverse demographics before any definitive conclusions can be drawn or changes in clinical practice can be made. If confirmed, these findings could influence how cardiologists and physicians choose between these medications for their patients.
